Literature DB >> 12082274

Integrins and cell signaling in chondrocytes.

Richard F Loeser1.   

Abstract

Integrins are adhesion receptor heterodimers that transmit information from the extracellular matrix (ECM) to the cell through activation of cell signaling pathways. Chondrocytes express several members of the integrin family including alpha5beta1 which is the primary chondrocyte receptor for fibronectin. Cell signaling mediated through integrins regulates several chondrocyte functions including differentiation, matrix remodeling, responses to mechanical stimulation and cell survival. Integrin-mediated activation of members of the mitogen-activated protein kinase family likely plays a key role in transmitting signals regulating chondrocyte gene expression. Upstream mediators of mitogen-activated protein kinase (MAP kinase) activation include focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (pyk2) which are both expressed by chondrocytes. A better understanding of chondrocyte integrin signaling is needed to define the mechanisms by which the ECM regulates chondrocyte function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082274

Source DB:  PubMed          Journal:  Biorheology        ISSN: 0006-355X            Impact factor:   1.875


  41 in total

1.  Cyclic strain stimulates proliferative capacity, alpha2 and alpha5 integrin, gene marker expression by human articular chondrocytes propagated on flexible silicone membranes.

Authors:  Kian Lahiji; Anna Polotsky; David S Hungerford; Carmelita G Frondoza
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 May-Jun       Impact factor: 2.416

2.  Modification of osteoarthritis in the guinea pig with pulsed low-intensity ultrasound treatment.

Authors:  I Gurkan; A Ranganathan; X Yang; W E Horton; M Todman; J Huckle; N Pleshko; R G Spencer
Journal:  Osteoarthritis Cartilage       Date:  2010-02-06       Impact factor: 6.576

3.  Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins.

Authors:  Faye Hui Chen; Ashby O Thomas; Jacqueline T Hecht; Mary B Goldring; Jack Lawler
Journal:  J Biol Chem       Date:  2005-07-28       Impact factor: 5.157

4.  Modulation of endochondral development of the distal femoral condyle by mechanical loading.

Authors:  Sona Sundaramurthy; Jeremy J Mao
Journal:  J Orthop Res       Date:  2006-02       Impact factor: 3.494

5.  The properties of chondrocyte membrane reservoirs and their role in impact-induced cell death.

Authors:  Eng Kuan Moo; Matthias Amrein; Marcelo Epstein; Mike Duvall; Noor Azuan Abu Osman; Belinda Pingguan-Murphy; Walter Herzog
Journal:  Biophys J       Date:  2013-10-01       Impact factor: 4.033

Review 6.  Biomaterial strategies for stem cell maintenance during in vitro expansion.

Authors:  Xiang-Zhen Yan; Jeroen J J P van den Beucken; Sanne K Both; Pi-Shan Yang; John A Jansen; Fang Yang
Journal:  Tissue Eng Part B Rev       Date:  2013-12-05       Impact factor: 6.389

Review 7.  Role of integrins and their ligands in osteoarthritic cartilage.

Authors:  Jian Tian; Fang-Jie Zhang; Guang-Hua Lei
Journal:  Rheumatol Int       Date:  2014-09-27       Impact factor: 2.631

8.  MiR-34a promotes Fas-mediated cartilage endplate chondrocyte apoptosis by targeting Bcl-2.

Authors:  Huajiang Chen; Jianxi Wang; Bo Hu; Xiaodong Wu; Yu Chen; Renhu Li; Wen Yuan
Journal:  Mol Cell Biochem       Date:  2015-04-25       Impact factor: 3.396

Review 9.  Basement membrane components are key players in specialized extracellular matrices.

Authors:  Jenny Kruegel; Nicolai Miosge
Journal:  Cell Mol Life Sci       Date:  2010-04-29       Impact factor: 9.261

10.  Perturbation of adhesion molecule-mediated chondrocyte-matrix interactions by 4-hydroxynonenal binding: implication in osteoarthritis pathogenesis.

Authors:  Rana El-Bikai; Mélanie Welman; Yoran Margaron; Jean-François Côté; Luke Macqueen; Michael D Buschmann; Hassan Fahmi; Qin Shi; Karim Maghni; Julio C Fernandes; Mohamed Benderdour
Journal:  Arthritis Res Ther       Date:  2010-10-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.